| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | uniporter activity | 1.11e-04 | 10 | 32 | 2 | GO:0015292 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 4.27e-04 | 1180 | 32 | 8 | GO:0022857 | |
| GeneOntologyMolecularFunction | transporter activity | 7.69e-04 | 1289 | 32 | 8 | GO:0005215 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | 1.21e-03 | 766 | 32 | 6 | GO:0016491 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.23e-03 | 296 | 32 | 4 | GO:0015291 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 2.06e-03 | 42 | 32 | 2 | GO:0015144 | |
| Domain | Sugar_transporter_CS | 1.75e-09 | 32 | 31 | 5 | IPR005829 | |
| Domain | MFS_dom | 1.90e-09 | 134 | 31 | 7 | IPR020846 | |
| Domain | MFS | 2.13e-08 | 108 | 31 | 6 | PS50850 | |
| Domain | MFS | 1.63e-07 | 77 | 31 | 5 | IPR011701 | |
| Domain | MFS_1 | 1.63e-07 | 77 | 31 | 5 | PF07690 | |
| Domain | SUGAR_TRANSPORT_2 | 2.77e-06 | 17 | 31 | 3 | PS00217 | |
| Domain | Pentapeptide_4 | 7.99e-06 | 3 | 31 | 2 | PF13599 | |
| Domain | SV2 | 7.99e-06 | 3 | 31 | 2 | IPR022308 | |
| Domain | 5peptide_repeat | 1.60e-05 | 4 | 31 | 2 | IPR001646 | |
| Domain | Sugar_tr | 2.85e-05 | 36 | 31 | 3 | PF00083 | |
| Domain | MFS_sugar_transport-like | 2.85e-05 | 36 | 31 | 3 | IPR005828 | |
| Domain | SUGAR_TRANSPORT_1 | 7.19e-04 | 24 | 31 | 2 | PS00216 | |
| Pathway | REACTOME_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_D_BOTD | 3.01e-05 | 5 | 25 | 2 | M27427 | |
| Pathway | REACTOME_NEUROTOXICITY_OF_CLOSTRIDIUM_TOXINS | 1.35e-04 | 10 | 25 | 2 | M27018 | |
| Pubmed | 4.32e-07 | 16 | 33 | 3 | 17715346 | ||
| Pubmed | No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy. | 2.62e-06 | 3 | 33 | 2 | 18977120 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 23617838 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 16543415 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 12687700 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 23937191 | ||
| Pubmed | SV2 modulates the size of the readily releasable pool of secretory vesicles. | 2.62e-06 | 3 | 33 | 2 | 11483953 | |
| Pubmed | Differentiation of two human neuroblastoma cell lines alters SV2 expression patterns. | 2.62e-06 | 3 | 33 | 2 | 33588752 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 25584868 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 25559186 | ||
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 15466855 | ||
| Pubmed | Pulmonary neuroendocrine cells, airway innervation, and smooth muscle are altered in Cftr null mice. | 1.31e-05 | 6 | 33 | 2 | 16614351 | |
| Pubmed | Synaptobrevin is essential for secretion but not for the development of synaptic processes. | 2.44e-05 | 8 | 33 | 2 | 8738414 | |
| Pubmed | 3.91e-05 | 10 | 33 | 2 | 10398046 | ||
| Pubmed | 3.91e-05 | 10 | 33 | 2 | 17038521 | ||
| Pubmed | Restoration of synapse formation in Musk mutant mice expressing a Musk/Trk chimeric receptor. | 4.78e-05 | 11 | 33 | 2 | 12403715 | |
| Pubmed | Multiple roles of integrin-α3 at the neuromuscular junction. | 5.73e-05 | 12 | 33 | 2 | 28386022 | |
| Pubmed | 6.77e-05 | 13 | 33 | 2 | 23637329 | ||
| Pubmed | 7.89e-05 | 14 | 33 | 2 | 12441053 | ||
| Pubmed | 7.89e-05 | 14 | 33 | 2 | 21228161 | ||
| Pubmed | 1.22e-04 | 101 | 33 | 3 | 9872452 | ||
| Pubmed | 1.32e-04 | 18 | 33 | 2 | 33514739 | ||
| Pubmed | 2.58e-04 | 25 | 33 | 2 | 36343752 | ||
| Pubmed | 3.99e-04 | 31 | 33 | 2 | 15217342 | ||
| Pubmed | β-Catenin gain of function in muscles impairs neuromuscular junction formation. | 4.81e-04 | 34 | 33 | 2 | 22627288 | |
| Pubmed | Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. | 5.06e-04 | 164 | 33 | 3 | 22967998 | |
| Pubmed | 5.68e-04 | 405 | 33 | 4 | 38187761 | ||
| Pubmed | 9.19e-04 | 47 | 33 | 2 | 31235642 | ||
| Pubmed | Activin A Determines Steroid Levels and Composition in the Fetal Testis. | 9.19e-04 | 47 | 33 | 2 | 32274496 | |
| GeneFamily | Solute carriers | 3.29e-05 | 395 | 18 | 5 | 752 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Serous_adenocarcinoma-3|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 5.40e-06 | 157 | 33 | 4 | ef70abc999be3a2c1eed7d21aef4b484f69d8567 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.67e-06 | 177 | 33 | 4 | aa56129d2d5a73a10e33b7162233a4d9337ee535 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-Migratory_DCs_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.67e-06 | 177 | 33 | 4 | d78a6003ce2d15d7771ae385de252eec7e3c3eea | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.67e-06 | 177 | 33 | 4 | 70ca5b6fde2e38af1eb88a7d6e8746edba298191 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-05 | 185 | 33 | 4 | b57dae20c21f984edd2acee4344d86f033108ebf | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-05 | 185 | 33 | 4 | d3b054d203e575c1bb5455aa7a2e551a0957a760 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_activated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-04 | 124 | 33 | 3 | e16be7805c91db12b1110c90cd39492913f1d3ea | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.81e-04 | 149 | 33 | 3 | c773c2b9685ec44a35246180a93456c8765353f5 | |
| ToppCell | Dendritic_Cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.88e-04 | 151 | 33 | 3 | e089bf197ed60e7243160521d4390d4b40a3832b | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma-7|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.19e-04 | 159 | 33 | 3 | 75a82bbabd97b168dbf1c3f43a9bdad48ce18c78 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.44e-04 | 165 | 33 | 3 | 1d0f60bf47a40ac916f0fcb5532a968742a0edbb | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.52e-04 | 167 | 33 | 3 | 43a9375fdbafd7450c553e4620e21537e08639dd | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_activated|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.61e-04 | 169 | 33 | 3 | 2098f15a388d019ed7f1d4c209affd5ca2886dcc | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 2.75e-04 | 172 | 33 | 3 | 38d17e769fe8eac8b57b820490d4ddd969243ee7 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-migDC|lymph-node_spleen / Manually curated celltypes from each tissue | 2.75e-04 | 172 | 33 | 3 | 1b24bed3cd8e3fa463c5e7cefdf9e99e639e2f84 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.80e-04 | 173 | 33 | 3 | 09a13407a41ff2cba82fc417b72bf9a24ce6c42e | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.80e-04 | 173 | 33 | 3 | bfec038a6783f166240da4861e100643c6ea80a5 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-aDC_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.99e-04 | 177 | 33 | 3 | ccf5dc54780d6039a4d062dee88440c011ddc0a3 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Activated_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.99e-04 | 177 | 33 | 3 | 370aee11a6dc2c6f4366a13c3171f37bc5b32d65 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 3.04e-04 | 178 | 33 | 3 | 9a3581a0158dfa5a1cc942f8c532afb5e38b272a | |
| ToppCell | wk_20-22-Hematologic-Myeloid-aDC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.04e-04 | 178 | 33 | 3 | fd2bdb4796e86c8cff2d25f0c730ffea21db8787 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.15e-04 | 180 | 33 | 3 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.20e-04 | 181 | 33 | 3 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | VE-matDC-|VE / Condition, Cell_class and T cell subcluster | 3.20e-04 | 181 | 33 | 3 | 6252184ef098b911df50be4fe1b5565849a5b6b8 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-aDC_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.20e-04 | 181 | 33 | 3 | 8f7e5c310f4cdc4b2fb54fea950d01e56bd298e1 | |
| ToppCell | VE-matDC|VE / Condition, Cell_class and T cell subcluster | 3.20e-04 | 181 | 33 | 3 | 982fd96ef75bc9ab2c2f4970c01b76ba7a164871 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC-cDC2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.25e-04 | 182 | 33 | 3 | 1d37c486173cc4629842893ddd5033987c04086f | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC-cDC2-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.25e-04 | 182 | 33 | 3 | aef67bdc6937b315522d39959e26c9b0acf7ab52 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.25e-04 | 182 | 33 | 3 | 087c9f88daf08f5d688b728c2386f91f210d2255 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-maDC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.30e-04 | 183 | 33 | 3 | e01dacb08a9c36cf09c0b6764ce032a7232d4cdc | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.35e-04 | 184 | 33 | 3 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | PBMC-Control-cDC_10|Control / Compartment, Disease Groups and Clusters | 3.41e-04 | 185 | 33 | 3 | 4b5a7450fed912f340da16065c1e65d626dbe8d1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.52e-04 | 187 | 33 | 3 | ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 3.57e-04 | 188 | 33 | 3 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic-CD141-positive_myeloid_dendritic_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.57e-04 | 188 | 33 | 3 | 78e79b8e298aa77c8c01320bab4fb1a00f11a772 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.57e-04 | 188 | 33 | 3 | ef3f6400c018834a8fd56893faa3476a0f10aedc | |
| ToppCell | (3)_DC_activated|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.63e-04 | 189 | 33 | 3 | e977838793fc0eb1499e81018e33e4ccb4a5f0c5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-04 | 189 | 33 | 3 | 851f8144aed5c7f80302911cd6b03f14bde7b56d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-04 | 189 | 33 | 3 | 3e8e30160a8d6f531ff743cb5918c9e79481f1bd | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.68e-04 | 190 | 33 | 3 | d24af6af3271e34afab744352afd28be8a7cc5c3 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 190 | 33 | 3 | 1c5cf933ce71fed5638b9ef31eb81f6c2b6dadbc | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.68e-04 | 190 | 33 | 3 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_mature_DC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.86e-04 | 193 | 33 | 3 | d9be4d1de863fffc2240d6fd1a2f8dfb2d2bc916 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic|Lung / Manually curated celltypes from each tissue | 3.86e-04 | 193 | 33 | 3 | 7bce609699c515d2d114596a0c527f90cc09c4af | |
| ToppCell | distal-Hematologic-Myeloid_Dendritic_Type_1-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.92e-04 | 194 | 33 | 3 | f0467d81063a9b19783906c456935ef8318b9b98 | |
| ToppCell | Control-Myeloid-Migratory_DC|Control / Condition, Lineage and Cell class | 3.92e-04 | 194 | 33 | 3 | 374076e60dcee83eb1814aa6b55b77668909f40b | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Activated_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 3.92e-04 | 194 | 33 | 3 | 219056d4ad256cda73208b8c570bbf689219df83 | |
| ToppCell | ILEUM-inflamed-(3)_mature_DC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.92e-04 | 194 | 33 | 3 | 369bbf4e8e2d674e5a51a614b52b97d05d3ab9c7 | |
| ToppCell | tumor_Lung-Myeloid_cells-Activated_DCs|tumor_Lung / Location, Cell class and cell subclass | 3.92e-04 | 194 | 33 | 3 | a85d958aff84f2296c330a7dcd442bd2344738df | |
| ToppCell | distal-1-Hematologic-Myeloid_Dendritic_Type_1|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.92e-04 | 194 | 33 | 3 | 85a4be291c25ad1fb14199b87d822cf47d748fc0 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic|lymph-node_spleen / Manually curated celltypes from each tissue | 3.92e-04 | 194 | 33 | 3 | e2d9186a7e8d1a4a71d7bd6dba7fc955d55479e6 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic|Lung / Manually curated celltypes from each tissue | 3.97e-04 | 195 | 33 | 3 | b748cb15846345363e8c2ee5936bb42bba3ba9a7 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.03e-04 | 196 | 33 | 3 | 95544097577f20ed7f4144bd940471cde0617554 | |
| ToppCell | medial-Hematologic-Myeloid_Dendritic_Type_1|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.09e-04 | 197 | 33 | 3 | 5bd2f32137fd849931e52093d630d2e7e27daf4f | |
| ToppCell | medial-Hematologic-Myeloid_Dendritic_Type_1-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.09e-04 | 197 | 33 | 3 | d9baa0be469fd8737a74b5078d30ce7d66759160 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Club|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.09e-04 | 197 | 33 | 3 | 01e9505d947e5a5f005d1eab96301f84fc194809 | |
| ToppCell | medial-2-Hematologic-Myeloid_Dendritic_Type_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.09e-04 | 197 | 33 | 3 | 3c1147857de6a7ab6b0cf77f5a6364d4c8669693 | |
| ToppCell | COVID-19-Myeloid-Migratory_DC|COVID-19 / Condition, Lineage and Cell class | 4.09e-04 | 197 | 33 | 3 | b6d6cdae33753c1e38394f1f879e00b87f9c0496 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC2-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.16e-04 | 198 | 33 | 3 | c58e2d3a21fcca9f1accccc5303ca4222b6c8432 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.16e-04 | 198 | 33 | 3 | e1df453729ec565f1a55a6c649e87aa9e0c5cacf | |
| ToppCell | distal-3-Hematologic-Myeloid_Dendritic_Type_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.16e-04 | 198 | 33 | 3 | b21227c7366ef79b36048509a91d2d35fd5e4956 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC2|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.16e-04 | 198 | 33 | 3 | f4ff9520598ebc52b3a1f31eee766957983e16b4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.16e-04 | 198 | 33 | 3 | 2cfdcbf33854f314c41ea0f01c31bc27b66c2f91 | |
| ToppCell | BAL-Severe-Myeloid-cDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.22e-04 | 199 | 33 | 3 | 0b20ae65b9340d844e271acda9e116d98fc1cc69 | |
| ToppCell | distal-Hematologic-Myeloid_Dendritic_Type_1-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.22e-04 | 199 | 33 | 3 | 3860f30114b54abff91898308df71b8b4e05b51e | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_activated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.22e-04 | 199 | 33 | 3 | 7b3d4c62b11268c7c1599600d8a7b331287cf21a | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.22e-04 | 199 | 33 | 3 | 9a0e853693e572c63b135f937b2cffd4dd4026fb | |
| ToppCell | Severe_COVID-19-Myeloid-cDC|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 4.22e-04 | 199 | 33 | 3 | 9132c1929d3445fcca49f76f010ca37adeb70315 | |
| ToppCell | BAL-Severe-Myeloid-cDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.22e-04 | 199 | 33 | 3 | d017848256704ae7237030868b143c3f0842a9c3 | |
| ToppCell | mLN-(5)_Dendritic_cell|mLN / shred on region, Cell_type, and subtype | 4.22e-04 | 199 | 33 | 3 | 4feecf533e29a1a558f1018a2e8f7bfa7b9d3864 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Dendritic_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.22e-04 | 199 | 33 | 3 | 946d904a880c0e211861fcec7e120853ffade282 | |
| ToppCell | BAL-Severe-cDC_10|Severe / Compartment, Disease Groups and Clusters | 4.22e-04 | 199 | 33 | 3 | 54bdadd04abaf8caa948b0177c037bc089ca07e6 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.22e-04 | 199 | 33 | 3 | bb9e7418468b88cdfaa78788d062362794ea8230 | |
| ToppCell | mLN-Dendritic_cell|mLN / Region, Cell class and subclass | 4.22e-04 | 199 | 33 | 3 | 597412beae1324b9c43ca2bb96c4cb645c19f3e9 | |
| ToppCell | distal-Hematologic-Myeloid_Dendritic_Type_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.22e-04 | 199 | 33 | 3 | 6fc8c321e2ddd802b9c8edfe16e006c7d4d862fc | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-cDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.28e-04 | 200 | 33 | 3 | 9744d53915c8dc9d5e011cbbb0ac7db44c615ce7 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.28e-04 | 200 | 33 | 3 | 1adebb306112bfc4926678de80f70d35dd57a586 | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-DCs|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.28e-04 | 200 | 33 | 3 | 6237e4b46b196e1d1610b2edc60af4716a6fed25 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-cDC-DCs-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.28e-04 | 200 | 33 | 3 | b52f7534a5ff504dccc002ebc30836a87e43c123 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.28e-04 | 200 | 33 | 3 | 0cb6e65f9efe1d4fd18b8ef4333cc39956cafdad | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-cDC-DCs|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.28e-04 | 200 | 33 | 3 | cb0ba75be8fb2ec47474559911df80d085c4dbc8 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2_(Retrosplenial_cortex_(RSG)/Subiculum/Parasubiculum)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.76e-04 | 48 | 33 | 2 | e96a608c2239f2ceb07d0a492289b24fabf190a1 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2_(Retrosplenial_cortex_(RSG)/Subiculum/Parasubiculum)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.76e-04 | 48 | 33 | 2 | 17cb229b199c49ec74d2230b1f8dbb0195b1bf01 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2_(Retrosplenial_cortex_(RSG)/Subiculum/Parasubiculum)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.76e-04 | 48 | 33 | 2 | c030dfb7c3289df7f34e91f31be6e9b47ca045f5 | |
| Disease | nucleotide measurement | 6.84e-05 | 73 | 32 | 3 | EFO_0010513 | |
| Disease | peptic ulcer disease | 5.89e-04 | 33 | 32 | 2 | MONDO_0004247 | |
| Disease | body weights and measures | 7.82e-04 | 38 | 32 | 2 | EFO_0004324 | |
| Disease | pain | 1.24e-03 | 196 | 32 | 3 | EFO_0003843 | |
| Disease | total blood protein measurement | 1.36e-03 | 449 | 32 | 4 | EFO_0004536 | |
| Disease | IGA glomerulonephritis | 1.81e-03 | 58 | 32 | 2 | EFO_0004194 | |
| Disease | lymphocyte count | 4.40e-03 | 1464 | 32 | 6 | EFO_0004587 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MGWSCLVTGAGGLLG | 1 | P26439 | |
| VGHWKEGKMCGQGVY | 1101 | Q96Q42 | |
| AYCDMEAGGGGWTII | 311 | O15123 | |
| GMQTKYLDVGWGLGS | 366 | P19801 | |
| GVKCGIIYWLFGGAI | 51 | Q9NUZ1 | |
| SMICGWDKKGPGLYY | 171 | P28062 | |
| YGGMSGCRLGDLWTL | 221 | P51610 | |
| LVLGCITMAYVWGKG | 81 | P14902 | |
| LYGGIAGGLMAIAWF | 166 | Q86YN1 | |
| YAGSMGESCGGLWLA | 136 | Q17RY6 | |
| KQAGGVDIGWTLGYM | 431 | Q5MY95 | |
| VAAWGVGGMLEGCGY | 171 | Q8WUY8 | |
| FGGGAGKYLAEWMVH | 391 | Q8NCN5 | |
| KGRGWGEGDFVYQCM | 111 | Q7L775 | |
| SYGWICDELMGGGGL | 161 | Q3B7J2 | |
| GMVGSILCGLWLDYT | 381 | Q9Y5Y0 | |
| MDCGSVFYIWVGKGC | 1161 | O95487 | |
| GVFGKGTWMTCYVIV | 216 | O75751 | |
| MWKGCLTLYTGRGGE | 81 | Q96AH0 | |
| GWLGSIVYLGMMVGA | 191 | Q496J9 | |
| DGKGGTGNWMSYVNC | 316 | Q9GZV8 | |
| GIAMAVVGYWPKATG | 66 | A6NKL6 | |
| FMKCGGGLLIGGQAW | 141 | Q9Y4C2 | |
| GSMCLFIAGFAVGWG | 376 | Q9NY64 | |
| GVCLGGYLMETTGSW | 386 | Q9BYT1 | |
| VYLGMMVGAFLWGGL | 211 | Q7L0J3 | |
| AGGLIYWIGLTKAGM | 246 | Q9UJ71 | |
| AGVKMGCWGLVIYAA | 556 | Q5BKX6 | |
| WMMGDGVLYGALDCG | 286 | Q9P253 | |
| FIAGIGGACWVILMG | 861 | Q9HCK4 | |
| VLGGFWAIGRYMKSG | 381 | Q495X7 | |
| GAWILTGGTHYGLMK | 176 | Q7Z2W7 | |
| LGLGGSCYAVWKMVG | 41 | A0A0U1RRA0 |